Skip to content

Functional Evaluation of Two Infant Formula Supplemented With Probiotics Isolated From Breast Milk

Functional Evaluation of Two Infant Formula Supplemented With Probiotics Isolated From Breast Milk

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03204630
Enrollment
236
Registered
2017-07-02
Start date
2011-01-31
Completion date
2015-12-31
Last updated
2017-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant Nutrition

Keywords

infant nutrition, probiotic

Brief summary

A randomized double blinded controlled study including infants at the age of 1 month . Infants are assigned randomly to either infant formula supplemented with B. breve CECT7263 or L.fermentum CECT5716 (Probiotic groups), or the same formula without the probiotic strain (Control group). The primary outcome of the study is the body weight gain of infants. Secondary outcomes are incidence of infections, symptoms related with intestinal function, and fecal microbiota

Interventions

DIETARY_SUPPLEMENTLfer

Probiotic bacteria originally isolated from breast milk: the strain Lactobacillus fermentum CECT5716

DIETARY_SUPPLEMENTBifido

Probiotic bacteria originally isolated from breast milk: the strain Bifidobacterium breve CECT7263

OTHERControl

Standard infant formula

Sponsors

Maimónides Biomedical Research Institute of Córdoba
CollaboratorOTHER
Andaluz Health Service
CollaboratorOTHER_GOV
Biosearch S.A.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
3 Weeks to 5 Weeks
Healthy volunteers
Yes

Inclusion criteria

* Newborn infants at term (37-42 weeks gestational age) healthy during the first month of life, for reasons unrelated to the study, abandon breastfeeding during the first month of life. * Signature of informed parental or guardian consent.

Exclusion criteria

* Allergic to the protein in cow's milk. * Lactose intolerant. * Suffering from a serious metabolic disease. * They have experienced or are experiencing some severe gastrointestinal disease. * Receive some form of chronic medication or are receiving antibiotics at the time of capture. * Low expectation of compliance with the study protocol. * allergic to any group of antibiotics.

Design outcomes

Primary

MeasureTime frameDescription
Body weight gain12 months versus baselineBody weight gain at 12 months (grams)

Secondary

MeasureTime frameDescription
Body weight1,2,4,6,9 and 12 months of ageBody weight of infants at different times (kg)
Incidence of infectionstotal incidence during intervention (11 months)Events of infections diseases during intervention period (Incidence rate)
Bacterial load in feces1,2,4,6,9 and 12 months of ageCounts of Lactobacillus, bifidobacteria, bacteroides, clostridium (CFU/g feces)
Regurgitationeach 2 weeks until 6 months of age and monthly until 12 months of ageMeasurement by score: 1 = not at all, 2 = regurgitation of small amounts during or shortly after feeding, 3 = larger regurgitation during or shortly after feeding, 4 = minor vomiting with time-lag to prior feeding, and 5 = severe vomiting with considerable loss of fluid.
Length1,2,4,6,9 and 12 months of ageLength (cm)
Infant coliceach 2 weeks until 6 months of age and monthly until 12 months of ageAverage crying hours per day during the last two days of each period of measurement which is each 2 weeks until 6 months of age and monthly until 12 months of age. Score: no crying; \< 3 hours/day; 3-6 hours/day; 6-12 hours/day; \> 12 hours/day
Flatulencyeach 2 weeks until 6 months of age and monthly until 12 months of ageAverage of duration of flatulence episodes (hours per day) during the last two days of each period of measurement which is each 2 weeks until 6 months of age and monthly until 12 months of age.Measurement by the score:no flatulency; \< 3 hours/day; 3-6 hours/day; 6-12 hours/day; \> 12 hours/day
Hours of night sleepeach 2 weeks until 6 months of age and monthly until 12 months of ageAverage of time of night sleep (hours per day) during the last two days of each period of measurement which is each 2 weeks until 6 months of age and monthly until 12 months of age.Measurement by the score: \< 4 hours ; 4-6 hours; 6-9 hours; 9-12 hours; \> 12 hours
Total hours of sleep/dayeach 2 weeks until 6 months of age and monthly until 12 months of ageAverage of total time of sleep (hours per day) during the last two days of each period of measurement which is each 2 weeks until 6 months of age and monthly until 12 months of age.Measurement by the score: \< 11 hours;  11-14 hours; 14-17 hours; 17-20 hours;  \> 20 hours
Fecal depositioneach 2 weeks until 6 months of age and monthly until 12 months of ageMeasurement by score:1 = \<1 time, 2 = 1-3, 3 = 4-6, 4 = 7-10, and 5 = \>10.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026